|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 368 SEK | -2.39% |
|
+1.43% | +28.04% |
| Apr. 18 | Transcript : Mycronic AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
| Apr. 18 | Mycronic AB Provides Sales Guidance for the Full Year 2024 | CI |
Redeye raises the valuation of
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source
| 1st Jan change | Capi. | |
|---|---|---|
| +28.04% | 3.29B | |
| +10.83% | 114B | |
| +28.81% | 97.06B | |
| +7.04% | 19.08B | |
| +3.52% | 18.7B | |
| +35.54% | 9.82B | |
| +11.69% | 8.4B | |
| -12.95% | 7.13B | |
| -29.73% | 5.59B | |
| +30.81% | 5.04B |
MYCRONIC AB 
